Intensity Therapeutics Inc (NASDAQ: INTS) established initial surge of 5.95% at $0.27, as the Stock market unbolted on Wednesday, before settling in for the price of $0.25 at the close. Taking a more long-term approach, INTS posted a 52-week range of $0.19-$3.40.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -23.29%. Meanwhile, its Annual Earning per share during the time was -23.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 67.74%. This publicly-traded company’s shares outstanding now amounts to $49.06 million, simultaneously with a float of $43.80 million. The organization now has a market capitalization sitting at $13.09 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2684, while the 200-day Moving Average is $0.9729.
Intensity Therapeutics Inc (INTS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Intensity Therapeutics Inc industry. Intensity Therapeutics Inc’s current insider ownership accounts for 10.72%, in contrast to 4.11% institutional ownership.
Intensity Therapeutics Inc (INTS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Intensity Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 67.74% and is forecasted to reach -0.23 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 38.66% through the next 5 years, which can be compared against the -23.29% growth it accomplished over the previous five years trading on the market.
Intensity Therapeutics Inc (NASDAQ: INTS) Trading Performance Indicators
Let’s observe the current performance indicators for Intensity Therapeutics Inc (INTS). It’s Quick Ratio in the last reported quarter now stands at 1.40.
In the same vein, INTS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.83, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.23 at the market close of one year from today.
Technical Analysis of Intensity Therapeutics Inc (INTS)
Now, what If we examine the latest scores posted by [Intensity Therapeutics Inc, INTS]. During the last 5-days, its volume was lower the volume of 2.32 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 45.38% While, its Average True Range was 53.73.
Raw Stochastic average of Intensity Therapeutics Inc (INTS) in the period of the previous 100 days is set at 16.49%, which indicates a major fall in contrast to 27.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0321 that was lower than 0.0322 volatility it exhibited in the past 100-days period.
